The patients with mutations in the WHD domain presented with mild inflammatory symptoms of FCAS4; whereas severe inflammation, MAS, and AIFEC, developed in those with mutations in the NBD and HD1 domains. This evidence concerns the gene NLRC4 and macrophage activation syndrome.